New Data from the RECOVER™ Study Reveal Two-Year Outcomes in People with Opioid Use Disorder Following Transition from Pivotal Phase 3 Clinical Trials to a Real-World Setting

The ongoing RECOVER™ study is assessing real-world, patient-centered outcomes including self-reported sustained illicit opioid-free weeks and life changes, such as improved health, employment status and connection to community following treatment with SUBLOCADE®

Slough, UK and Richmond, VA, June 24, 2020 – Indivior PLC (LON: INDV) announces new data from the two-year analysis of the 24-month real-world observational study, RECOVER™ (Remission from Chronic Opioid Use—Studying Environmental and SocioEconomic Factors on Recovery).

Read full report here.